Abstract:Objective To detect serum levels of estrogen,FSH and LH of perimenopausal and postmenopausal women with depressive disorder and observe clinical therapeutic effect of estrogen therapy(ET) on depressive disorder of the perimenopausal and postmenopausal women.Methods Serum levels of estrogen,FSH and LH of 30 perimenopausal and postmenopausal women with depressive disorder and 30 normal perimenopausal and postmenopausal women were detected by using magnetism-ELISA.44 perimenopausal and postmenopausal women with depressive disorder received 2.5mg/day of tibolone(estrogen) for two weeks and a maintainence dose of 1.25mg/day from the third week for 6 weeks(estrogen alone group),and other 40 perimenopausal and postmenopausal women with depressive disorder received combination of same dose of estrogen and 20mg of paroxitin(an antidepressant) at the same time(combination treatment group).23 women lost in the trail.Hamilton Depression Rating Scale(HDRS) was used to evaluate therapeutic effect for depressive disorder of the women and Kupperman index(KMI) was used to evaluate perimenopausal and postmenopausal symptoms of the women at baseline and the eighth week of treatment(end of the trail).Results The serum level of estrogen of perimenopausal and postmenopausal women with depressive disorder was lower than that of those normal perimenopausal and postmenopausal women(P<0.05).No difference was found in FSH and LH between the two groups.All the women in the two groups showed a significant reduction in HDRS and KMI scores at the end of the 8-week trial(both P<0.01).In the combined treatment group,HDRS score decrease rate was 70.53% and that in the estrogen alone group was 58.24%,and there was a significant difference between the two groups(P<0.05).The total effective rate for depressive disorder in the combined treatment group was 93.33% and that in the estrogen alone group was 80% and there was no significant difference between the two groups(P>0.05).In the combined treatment group,KMI score decrease rate was 73.99% and that in the estrogen alone group was 70.66%,and there was no significant difference between the two groups(P>0.05),and the total effective rate for perimenopausal and postmenopausal symptoms in the combined treatment group was 93.33% and that in the estrogen alone group was 80% and there was no significant difference between the two groups(P>0.05).Conclusion Perimenopausal and postmenopausal depressive disorder is correlated with decreased serum estrogen level of the women.So,estrogen is effective for perimenopausal and postmenopausal women with depressive disorder.Combination of antidepressant and estrogen is the best solution for perimenopausal and postmenopausal depressive disorder,but the treatment should be individualized.

Study on the effect of small-dose estrogen on postmenopausal patients with urinary tract infection

Analysis of the Addition of Estrogens' Action in Treating Urethra Infection in Old Women

Clinical analysis of sex hormone levels in postmenopausal women with urinary tract infection

Preventive effect of estrio-ointment for recurrent urethra infection in post-menopause women

[Study of Blood Flow Improvement of Topical Application of Estrogen on Low Genitourinary Tract and Its Safety].

Alterations of Estrogen Receptor-Α and -Β in the Anterior Vaginal Wall of Women with Urinary Incontinence

Preventive Effects of Small Dose Estrogen and Progesterone on Prevention and Treatment of Perimenopausal Osteoporosis

Effectiveness and safety of patient-initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: A randomized controlled study

Comparison of Two Antibiotic Prophylaxis Schemes for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women

Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial

Investigating the Impact of Estrogen Levels on Voiding Characteristics, Bladder Structure, and Related Proteins in a Mouse Model of Menopause-Induced Lower Urinary Tract Symptoms

Effect of tolterodine combined with Suoquan pill on overactive bladder in postmenopausal women

Vaginal Estrogen Therapy Is Associated With Decreased Inflammatory Response in Postmenopausal Women With Recurrent Urinary Tract Infections

Topical estrogen therapy ameliorates bladder estrogen receptor β expression in female patients with overactive bladder

Effects of Different Treatment Methods on the Clinical and Urodynamic State of Perimenopausal Women with Stress Urinary Incontinence

Recurrent Urinary Tract Infection and Estrogen Shape the Taxonomic Ecology and Function of the Postmenopausal Urogenital Microbiome.

Postmenopausal Osteoporosis Treated by Hormone Replacement Therapy (HRT) with Small Dose of Estrogen

Urinary Tract Infection in Postmenopausal Women

Effect of estrogen on depressive disorder of perimenopausal and postmenopausal women

Clinical Observation of Premarin Ointment and Zhibai Dihuang Pill in the Treatment of Recurrent Urogenital Infection of Postmenopausal Women

Professor Qin Liangfu′s Experience of Treating Urinary Tract Infectionin Perimenopausalwomen